Funding Health Guidelines Disease Surveillance U.S. Withdrawal Health Alerts Health Policy Health Reports Emergency Response Humanitarian Aid Risk Assessment Disease Statistics Pandemic Preparedness Health Emergencies US Withdrawal Disease Prevention Public Health Emergencies Disease Response COVID-19 Pandemic Response Funding Issues Disease Control Health Initiatives Variant Classification Health Risk Assessment Tuberculosis Tedros Adhanom Ghebreyesus Health Responses Epidemics Leadership Health Recommendations Health Policies U.S. Involvement Disease Monitoring Disease Reporting Disease Management Health Statistics Annual Meeting Epidemic Preparedness Leadership Changes Violence in Sudan Conflict Impact COVID-19 Response Tuberculosis Statistics Health Warnings Dengue Awareness Flu Season Impact Disease Preparedness Disease Fatality Rates Recommendations Health Coverage Measles Outbreak International Collaboration Dr. Tedros Adhanom Budgeting U.S. Health Policy Zoonotic Diseases U.S. Relations with WHO U.S. Contributions Pan American Health Organization Health Advisories Reports Disease Guidelines Health Risks Influenza Alerts Health Security Health Governance Malaria Control Emergency Declarations Vaccination Campaigns Regional Offices Covid-19 Data Public Health Initiatives Variant Surveillance Investment in Health Disease Classification Public Health Emergency Humanitarian Response Disease Outbreaks Variant Monitoring Vaccination Initiatives Public Health Financial Management Emergency Use Listing Disease Notifications Public Health Policy Vaccine Recommendations Covid-19 Variants Tedros Ghebreyesus Financial Crisis Disease Warnings Budget Management Humanitarian Missions Disease Elimination Health Infrastructure Vaccine Approval Ebola Outbreaks International Response International Health Policy Priority Pathogens Ebola Vaccination
The recommendation mirrors WHO strains, with a final decision pending from FDA Commissioner Martin Makary.
